While these findings suggest that KIF5B might be involved in tau regulation and Alzheimer’s disease (AD), the precise molecular mechanisms through which KIF5B regulates tau degradation remain unclear. The gene discussed is MAPT; the disease is early-onset autosomal dominant Alzheimer disease.